Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02403401 · ClinicalTrials.gov registry record · Phase 3
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
A Phase 3 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,471
- Enrollment target
NCT02403401 is a Phase 3 study that has completed, run by Bayer. The registered enrollment target is 1,471 participants.
The verdict
NCT02403401, a Phase 3 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,471 participants
- Enrollment target
Study Summary
Purpose of the study is to investigate safety and contraceptive efficacy of an LNG-containing intravaginal ring.
Interventions
- DRUG Levonorgestrel (BAY98-7196)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,471 participants |
| Start Date | 2015-05-15 |
| Est. Completion | 2016-07-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02403401
The ClinicalTrials.gov registry entry for NCT02403401 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,471 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Levonorgestrel (BAY98-7196) is the first listed.
NCT02403401 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02403401 about?
NCT02403401 is a clinical study titled "Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women". Purpose of the study is to investigate safety and contraceptive efficacy of an LNG-containing intravaginal ring.
What is the current status of trial NCT02403401?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,471 participants. The study started on 2015-05-15. Estimated completion is 2016-07-07.
What interventions are being tested in trial NCT02403401?
The interventions under investigation include: Levonorgestrel (BAY98-7196) (DRUG).
Who is sponsoring clinical trial NCT02403401?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.